Evidence map›Paper›PMID 25209926›Full record

Trial reportBJOG : an international journal of obstetrics and gynaecology2015

Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.

B Martinez de Tejada, A Karolinski, M C Ocampo, C Laterra, I Hösli, D Fernández, D Surbek, M Huespe, G Drack, A Bunader and 25 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in BJOG : an international journal of obstetrics and gynaecology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03202836 (Vaginal Progesterone Supplementation in the Management of Preterm Labor), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03202836 nacompletednot on this mapstarted 2017, after this paper: background citation

Vaginal Progesterone Supplementation in the Management of Preterm Labor: A Randomized, Double Blind, Controlled Trial

TypeinterventionalSponsorChulalongkorn UniversityRan2017 to 2018Enrolled90ConditionsPreterm LaborArmsprogesterone, Tocolytics, Steroids
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Preventing Preterm Birth: The Search for Tocolytic Synergism.Reproductive sciences (Thousand Oaks, Calif.) · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

35 authors at 15 institutions in 4 countries.

B Martinez de TejadaDepartment of Obstetrics and Gynaecology, Faculty of Medicine, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
A Karolinski
M C Ocampo
C Laterra
I Hösli
D Fernández
D Surbek
M Huespe
G Drack
A Bunader
S Rouillier
G López de Degani
E Seidenstein
E Prentl
J Antón
F Krähenmann
D Nowacki
M Poncelas
J C Nassif
R Papera
C Tuma
R Espoile
O Tiberio
G Breccia
A Messina
B Peker
E Schinner
B W Mol
L Kanterewicz
V Wainer
M Boulvain
V Othenin-Girard
M V Bertolino
O Irion
4P trial group
El Hospital General de Agudos Carlos G. Durand · ARUniversity of Geneva · CHAmsterdam UMC Location University of Amsterdam · NLArgerich Hospital · ARBernardino Rivadavia Natural Sciences Museum · ARHospital Donación Francisco Santojanni · ARHospital General de Agudos Dr. TEODORO ALVAREZ · ARKantonsspital St. Gallen · CHMagdalena Villegas de Martínez el Hospital · ARServicio Diabetología Hospital Córdoba · ARUniversity Hospital of Basel · CHUniversity Hospital of Lausanne · CHUniversity Hospital of Zurich · CHUniversity of Bern · CHWinterthur Museum Garden and Library · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the effectiveness of 200 mg of daily vaginal natural progesterone to prevent preterm birth in women with preterm labour.

designMulticentre, randomised, double-blind, placebo-controlled trial.

settingTwenty-nine centres in Switzerland and Argentina. POPULATION: A total of 385 women with preterm labour (24(0/7) to 33(6/7) weeks of gestation) treated with acute tocolysis.

methodsParticipants were randomly allocated to either 200 mg daily of self-administered vaginal progesterone or placebo within 48 hours of starting acute tocolysis.

main outcome measuresPrimary outcome was delivery before 37 weeks of gestation. Secondary outcomes were delivery before 32 and 34 weeks, adverse effects, duration of tocolysis, re-admissions for preterm labour, length of hospital stay, and neonatal morbidity and mortality. The study was ended prematurely based on results of the intermediate analysis.

resultsPreterm birth occurred in 42.5% of women in the progesterone group versus 35.5% in the placebo group (relative risk [RR] 1.2; 95% confidence interval [95% CI] 0.93-1.5). Delivery at <32 and <34 weeks did not differ between the two groups (12.9 versus 9.7%; [RR 1.3; 95% CI 0.7-2.5] and 19.7 versus 12.9% [RR 1.5; 95% CI 0.9-2.4], respectively). The duration of tocolysis, hospitalisation, and recurrence of preterm labour were comparable between groups. Neonatal morbidity occurred in 44 (22.8%) cases on progesterone versus 35 (18.8%) cases on placebo (RR: 1.2; 95% CI 0.82-1.8), whereas there were 4 (2%) neonatal deaths in each study group.

conclusionThere is no evidence that the daily administration of 200 mg vaginal progesterone decreases preterm birth or improves neonatal outcome in women with preterm labour.

Indexed as

Birth WeightAdministration, IntravaginalAdultApgar ScoreDouble-Blind MethodFemaleHumansIndomethacinInfantInfant MortalityInfant, NewbornIntensive Care Units, NeonatalObstetric Labor, PrematurePregnancyPregnancy Trimester, SecondPregnancy Trimester, ThirdIndomethacinProgesteroneProgestinsReceptors, OxytocinTocolytic AgentsMaternal toleranceneonatal morbidityneonatal mortalityneonatologyobstetricspreterm deliverypreterm labourvaginal progesterone

Identifiers

PMID25209926
OpenAlexW1976225382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.